Selected article for: "clinical study and study objective"

Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
  • ID: roslkxeq_336
    Snippet: Disclosures: No disclosures to report. In humans, pretreatment plasma D-dimer levels have been reported to predict survival in several types of malignancies. The objective of this study was to evaluate the prognostic value of pretreatment D-dimer levels in dogs with high-grade lymphoma. Forty-eight owned-dogs with multicentric high-grade lymphoma were enrolled in a prospective and observational clinical study. Signalments, clinical findings, hist.....
    Document: Disclosures: No disclosures to report. In humans, pretreatment plasma D-dimer levels have been reported to predict survival in several types of malignancies. The objective of this study was to evaluate the prognostic value of pretreatment D-dimer levels in dogs with high-grade lymphoma. Forty-eight owned-dogs with multicentric high-grade lymphoma were enrolled in a prospective and observational clinical study. Signalments, clinical findings, histology and cytology reports, immunophenotype, complete clinical staging and response to treatment were recorded for all dogs according to the WHO classification. Pretreatment D-dimer levels were measured with a quantitative D-dimer turbidometric immunoassay (Nyco Card Reader II, NYCOMED).

    Search related documents:
    Co phrase search for related documents